Nonfunctioning Pancreatic Endocrine Tumors: A Multicenter Clinical Study

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2435-2439

  Gullo, Lucio ^a   Migliori, Marina ^b   Falconi, Massimo ^b   Pederzoli, Paolo ^b   Bettini, Rossella ^b   Casadei, Riccardo ^b   Delle Fave, Gianfranco ^b   Corleto, Vito D ^b   Ceccarelli, Claudio ^b   Santini, Donatella ^b   Tomassetti, Paola ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAIN; PANCREAS; PANCREAS CARCINOMA; PANCREAS ISLET CELL TUMOR; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYMPTOMATOLOGY; TUMOR VOLUME; ULTRASOUND;

EID: 0344496213     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07704.x     Document Type: Article

References (34)

1. Broder LE, Carter SK. Pancreatic islet cell carcinoma. Ann Intern Med 1973;79:101-7.
2. Kent RB, van Heerden JA, Wheiland LH. Nonfunctioning islet cell tumors. Ann Surg 1981;193:185-90.
3. Dial PF, Braasch JW, Rossi RL, et al. Management of nonfunctioning islet cell tumors of the pancreas. Surg Clin North Am 1985;65:291-9.
4. Broughan TA, Leslie JD, Soto JM, Hermann RE. Pancreatic islet cell tumors. Surgery 1986;99:671-7.
5. Thompson GB, van Heerden JA, Grant CS, et al. Islet cell carcinomas of the pancreas: A twenty-year experience. Surgery 1988;104:1011-7.
6. Eriksson B, Oberg K, Skogseid B. Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol 1989;28:373-7.
7. Venkatesh S, Ordonez NG, Ajani J, et al. Islet cell carcinoma of the pancreas. A study of 98 patients. Cancer 1990;65:354-7.
8. Madura JA, Cummings OW, Wiebke EA, et al. Nonfunctioning islet cell tumors of the pancreas: A difficult diagnosis but one worth the effort. Am Surg 1997;63:573-8.
9. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422-7.
10. Jordan PH Jr. A personal experience with pancreatic and duodenal neuroendocrine tumors. J Am Coll Surg 1999;189:470-82.
11. Moldrow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968;55:677-86.
12. Eriksson B, Arnberg H, Lindgren PG, et al. Neuroendocrine pancreatic tumours: Clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med 1990;228:103-13.
13. Gibril F, Jensen RT. Pancreatic endocrine tumors: Recent insights. Clin Perspect Gastroenterol 2001;4:19-29.
14. Prinz RA, Badrinath K, Chejfec G, et al. Nonfunctioning islet cell carcinoma of the pancreas. Am Surg 1983;49:345-9.
15. Eckhauser FE, Cheung PS, Vinik AI, et al. Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery 1986;100:978-88.
16. Evans DB, Skibber JM, Lee JE, et al. Nonfunctioning islet cell carcinoma of the pancreas. Surgery 1993;114:1175-82.
17. Solcia E, Sessa F, Rindi G, et al. Pancreatic endocrine tumors: General concepts; nonfunctioning tumors and tumors with uncommon function. In: Dayal Y, ed. Endocrine pathology of the gut and pancreas. Boca Raton, FL: CRC Press, 1991:105-31.
18. Gullo L, Pezzilli R, Morselli-Labate AM, and the Italian Pancreatic Cancer Study Group. Coffee and cancer of the pancreas: An Italian multicentre study. Pancreas 1995;11:223-9.
19. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309:901-11.
20. Durbec JP, Chevilotte G, Bidart JM, et al. Diet, alcohol, tobacco and risk of cancer of the pancreas. A case-control study. Br J Cancer 1983;47:463-70.
21. Olsen GW, Mandel JS, Gibson RW, et al. A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health 1989;79:1016-9.
22. Consiglio Sanitario Nazionale. Relazione sullo stato sanitario del paese. 1989. I. Roma: Istituto Poligrafico e Zecca dello Stato, 1992.
23. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer: A meta-analysis. JAMA 1995;273:1605-9.
24. Gullo L, Pezzilli R, Morselli-Labate AM, and the Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994;331:81-4.
25. Morsiani M. Epidemiologia del diabete in Italia. Metabolismo Oggi 1987;4:3-10.
26. Ghadirian P, Boyle P, Simard A, et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-96.
27. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
28. Eusebi V, Capella C, Bondi A, et al. Endocrine-paracrine cells in pancreatic exocrine carcinomas. Histopathology 1981;5:599-613.
29. Reid JD, Yuh SL, Petrelli M, Jaffe R. Ductuloinsular tumors of the pancreas: A light, electron microscopic and immunohistochemical study. Cancer 1982;49:908-15.
30. Klimstra DS, Rosai J, Heffess CS. Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 1994;18:765-78.
31. Cello JP. Pancreatic cancer. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtran's gastrointestinal and liver disease. Pathophysiology, diagnosis, management, 6th ed, vol 1. 1998:863-70.
32. Gullo L, Tomassetti P, Migliori M, et al. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis? Pancreas 2001;22:210-3.
33. Kloppel G, Schroder S, Heitz PU. Histopathology and immunopathology of the pancreatic endocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas. Recent advances in research and management. Basel: Karger, 1995:99-120.
34. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996;429:323-33.